Investigating the Therapeutic Potential of Moringa oleifera to Reverse Nyaope Systemic Behavioral Patterns

Nyaope, a highly addictive high-grade heroin mixture combined with various adulterants, presented a severe socio-economic and public health crisis in South Africa. The administration of chronic exposure to nyaope induces systemic neurobehavioral alterations, including severe anxiety, motor deficits, cognitive impairment, and profound withdrawal-induced behavioral dysregulation. Moringa oleifera (MO), a botanical resource rich in bioactive flavonoids, alkaloids, and antioxidants, exhibits significant neuroprotective, anti-inflammatory, and anxiolytic properties. This study investigated the therapeutic potential of MO leaf extracts to reverse nyaope-induced systemic behavioral patterns using an in vivo rodent model. In the project, both male and female Wistar rats were monitored over nine (9) weeks in the Wits animal care center. The behavioral patterns that might be altered were investigated using the for-locomotor activity (Open Field Test), spatial working memory (Y-Maze), anxiety-like behavior (elevated plus maze) and cognitive memory (novel object recognition). The data were analyzed on a GraphPad Prism (Version 9.02) using repeated measures two-way and one-way ANOVAs, followed by appropriate post-hoc tests (p-value < 0.05). Most behavioral assessment tests demonstrated improved behavioral responses in the animal models following treatment with Moringa oleifera (MO). Overall, these findings suggest that MO treatment may have exerted beneficial effects on the behavioral outcomes assessed in the animal models. These findings demonstrate that administration of MO possesses potent neuroprotective properties. Crucially, treatment with MO significantly attenuated nyaope-induced behavioral alterations, restoring normal locomotor patterns and reducing anxiety-like traits. The findings indicate that MO exerts potential neuroprotective effects capable of mitigating and reversing systemic neurobehavioral disruptions caused by nyaope. Consequently, MO represents a promising naturally derived therapeutic candidate for mitigating neurochemical dysregulation and behavioral addiction patterns associated with nyaope abuse. There is a need for further research to assess the morphological modifications in the hippocampus and prefrontal cortex.